Mersana Therapeutics (MRSN) Earnings Date & Reports

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRSN is expected to report earnings to rise 76.64% to -19 cents per share on May 12

Mersana Therapeutics MRSN Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.04

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.02

The last earnings report on March 03 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 1.86M shares outstanding, the current market capitalization sits at 45.15M.

View a ticker or compare two or three

Compare

MRSN